CA Stock MarketDetailed Quotes

DTC Defence Therapeutics Inc

Watchlist
  • 0.790
  • 0.0000.00%
15min DelayTrading Apr 24 10:34 ET
43.23MMarket Cap-8.78P/E (TTM)

Defence Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-92.45%627.5K
-75.94%508.67K
95.89%12.82M
-31.16%1.19M
-2.56%1.21M
334.29%8.31M
27.13%2.11M
-10.58%6.55M
-20.49%1.73M
-25.95%1.24M
Selling and administrative expenses
-95.81%254.74K
32.67%154.81K
803.52%6.73M
-35.80%-1.28M
-53.01%439.14K
935.47%6.08M
-28.52%116.69K
-77.78%744.57K
-225.60%-940.35K
45.66%934.45K
-Selling and marketing expense
----
----
----
----
-73.34%205.19K
----
----
----
----
50.21%769.52K
-General and administrative expense
-95.81%254.74K
32.67%154.81K
803.52%6.73M
57.25%296.13K
41.84%233.95K
1,730.56%6.08M
97.27%116.69K
-9.93%744.57K
-28.59%188.31K
27.63%164.93K
Research and development costs
-85.96%220.15K
-88.03%126.34K
7.82%3.86M
-4.63%596.7K
148.67%641.86K
25.93%1.57M
-27.36%1.06M
-4.76%3.58M
-54.31%625.69K
-73.88%258.12K
Depreciation amortization depletion
154.88%17.71K
38.50%17.71K
557.77%90.92K
6,064.39%48.64K
7,813.33%22.55K
-45.50%6.95K
--12.79K
--13.82K
--789
--285
-Depreciation and amortization
154.88%17.71K
38.50%17.71K
557.77%90.92K
6,064.39%48.64K
7,813.33%22.55K
-45.50%6.95K
--12.79K
--13.82K
--789
--285
Other operating expenses
-79.35%134.9K
-77.43%209.81K
-2.87%2.14M
-10.80%1.82M
116.99%106.64K
855.51%653.3K
1,864.98%929.79K
955.13%2.21M
3,696.85%2.04M
3.73%49.15K
Operating profit
92.45%-627.5K
75.94%-508.67K
-95.89%-12.82M
31.16%-1.19M
2.56%-1.21M
-334.29%-8.31M
-27.13%-2.11M
10.58%-6.55M
20.49%-1.73M
25.95%-1.24M
Net non-operating interest income (expenses)
-105.24%-109.43K
-33.44%-107.97K
-46.79%-375.97K
-43.61%-148.61K
8.34%-93.13K
-4.47%-53.32K
-80.91K
-256.12K
-103.48K
-101.6K
Non-operating interest income
--0
-99.59%62
221.43%21.89K
4,985.71%356
-74.67%1.72K
--4.76K
--15.05K
--6.81K
--7
--6.8K
Non-operating interest expense
88.43%109.43K
12.58%108.03K
51.31%397.85K
43.94%148.96K
-12.50%94.86K
13.79%58.08K
--95.96K
--262.93K
--103.49K
--108.41K
Other net income (expenses)
-262.65%-67.91K
694.35%9.78K
107.24%4.8K
-219.31%-10.87K
-5,447.05%-24.44K
274.76%41.75K
95.83%-1.65K
-177.79%-66.3K
47.19%-3.4K
102.62%457
Gain on sale of security
-262.65%-67.91K
694.35%9.78K
107.24%4.8K
-219.31%-10.87K
-5,447.05%-24.44K
274.76%41.75K
95.83%-1.65K
-177.79%-66.3K
47.19%-3.4K
102.62%457
Income before tax
90.33%-804.84K
72.38%-606.86K
-92.10%-13.19M
26.48%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
6.48%-6.87M
15.82%-1.83M
20.74%-1.34M
Income tax
0
-105K
Earnings from equity interest net of tax
Net income
90.33%-804.84K
72.38%-606.86K
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.91%-6.76M
20.64%-1.73M
20.74%-1.34M
Net income continuous operations
90.33%-804.84K
72.38%-606.86K
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.91%-6.76M
20.64%-1.73M
20.74%-1.34M
Noncontrolling interests
Net income attributable to the company
90.33%-804.84K
72.38%-606.86K
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.91%-6.76M
20.64%-1.73M
20.74%-1.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
90.33%-804.84K
72.38%-606.86K
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.91%-6.76M
20.64%-1.73M
20.74%-1.34M
Diluted earnings per share
89.47%-0.02
80.00%-0.01
-76.47%-0.3
25.00%-0.03
0.00%-0.03
-280.00%-0.19
0.00%-0.05
15.00%-0.17
33.33%-0.04
40.00%-0.03
Basic earnings per share
89.47%-0.02
80.00%-0.01
-76.47%-0.3
25.00%-0.03
0.00%-0.03
-280.00%-0.19
0.00%-0.05
15.00%-0.17
33.33%-0.04
40.00%-0.03
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -92.45%627.5K-75.94%508.67K95.89%12.82M-31.16%1.19M-2.56%1.21M334.29%8.31M27.13%2.11M-10.58%6.55M-20.49%1.73M-25.95%1.24M
Selling and administrative expenses -95.81%254.74K32.67%154.81K803.52%6.73M-35.80%-1.28M-53.01%439.14K935.47%6.08M-28.52%116.69K-77.78%744.57K-225.60%-940.35K45.66%934.45K
-Selling and marketing expense -----------------73.34%205.19K----------------50.21%769.52K
-General and administrative expense -95.81%254.74K32.67%154.81K803.52%6.73M57.25%296.13K41.84%233.95K1,730.56%6.08M97.27%116.69K-9.93%744.57K-28.59%188.31K27.63%164.93K
Research and development costs -85.96%220.15K-88.03%126.34K7.82%3.86M-4.63%596.7K148.67%641.86K25.93%1.57M-27.36%1.06M-4.76%3.58M-54.31%625.69K-73.88%258.12K
Depreciation amortization depletion 154.88%17.71K38.50%17.71K557.77%90.92K6,064.39%48.64K7,813.33%22.55K-45.50%6.95K--12.79K--13.82K--789--285
-Depreciation and amortization 154.88%17.71K38.50%17.71K557.77%90.92K6,064.39%48.64K7,813.33%22.55K-45.50%6.95K--12.79K--13.82K--789--285
Other operating expenses -79.35%134.9K-77.43%209.81K-2.87%2.14M-10.80%1.82M116.99%106.64K855.51%653.3K1,864.98%929.79K955.13%2.21M3,696.85%2.04M3.73%49.15K
Operating profit 92.45%-627.5K75.94%-508.67K-95.89%-12.82M31.16%-1.19M2.56%-1.21M-334.29%-8.31M-27.13%-2.11M10.58%-6.55M20.49%-1.73M25.95%-1.24M
Net non-operating interest income (expenses) -105.24%-109.43K-33.44%-107.97K-46.79%-375.97K-43.61%-148.61K8.34%-93.13K-4.47%-53.32K-80.91K-256.12K-103.48K-101.6K
Non-operating interest income --0-99.59%62221.43%21.89K4,985.71%356-74.67%1.72K--4.76K--15.05K--6.81K--7--6.8K
Non-operating interest expense 88.43%109.43K12.58%108.03K51.31%397.85K43.94%148.96K-12.50%94.86K13.79%58.08K--95.96K--262.93K--103.49K--108.41K
Other net income (expenses) -262.65%-67.91K694.35%9.78K107.24%4.8K-219.31%-10.87K-5,447.05%-24.44K274.76%41.75K95.83%-1.65K-177.79%-66.3K47.19%-3.4K102.62%457
Gain on sale of security -262.65%-67.91K694.35%9.78K107.24%4.8K-219.31%-10.87K-5,447.05%-24.44K274.76%41.75K95.83%-1.65K-177.79%-66.3K47.19%-3.4K102.62%457
Income before tax 90.33%-804.84K72.38%-606.86K-92.10%-13.19M26.48%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M6.48%-6.87M15.82%-1.83M20.74%-1.34M
Income tax 0-105K
Earnings from equity interest net of tax
Net income 90.33%-804.84K72.38%-606.86K-95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.91%-6.76M20.64%-1.73M20.74%-1.34M
Net income continuous operations 90.33%-804.84K72.38%-606.86K-95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.91%-6.76M20.64%-1.73M20.74%-1.34M
Noncontrolling interests
Net income attributable to the company 90.33%-804.84K72.38%-606.86K-95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.91%-6.76M20.64%-1.73M20.74%-1.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 90.33%-804.84K72.38%-606.86K-95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.91%-6.76M20.64%-1.73M20.74%-1.34M
Diluted earnings per share 89.47%-0.0280.00%-0.01-76.47%-0.325.00%-0.030.00%-0.03-280.00%-0.190.00%-0.0515.00%-0.1733.33%-0.0440.00%-0.03
Basic earnings per share 89.47%-0.0280.00%-0.01-76.47%-0.325.00%-0.030.00%-0.03-280.00%-0.190.00%-0.0515.00%-0.1733.33%-0.0440.00%-0.03
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.

Unlock Now